Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Katsunori Matsushita
Front Cover: A Hydrogen Peroxide Activatable Gemcitabine Prodrug for the Selective Treatment of Pancreatic Ductal Adenocarcinoma (ChemMedChem 15/2019)
ChemMedChem
Organic Chemistry
Molecular Medicine
Pharmacology
Biochemistry
Toxicology
Drug Discovery
Pharmaceutics
Related publications
The Anti-Fibrotic Effect of GV1001 Combined With Gemcitabine on Treatment of Pancreatic Ductal Adenocarcinoma
Oncotarget
Oncology
Outcomes of Gemcitabine Treatment for Invasive Ductal Pancreatic Cancer
Suizo
Development and in Vitro Characterization of a Gemcitabine-Loaded MUC4-targeted Immunoliposome Against Pancreatic Ductal Adenocarcinoma
Anticancer Research
Medicine
Cancer Research
Oncology
ST6Gal-I Sialyltransferase Promotes Chemoresistance in Pancreatic Ductal Adenocarcinoma by Abrogating Gemcitabine-Mediated DNA Damage
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Cyr61/Ccn1 Regulates dCK and CTGF and Causes Gemcitabine Resistant Phenotype in Pancreatic Ductal Adenocarcinoma
Molecular Cancer Therapeutics
Cancer Research
Oncology
Nationwide Trends in Incidence, Treatment and Survival of Pancreatic Ductal Adenocarcinoma
European Journal of Cancer
Cancer Research
Oncology
Neoadjuvant Treatment With Gemcitabine Plus Nab-Paclitaxel Versus Surgery First for Pancreatic Adenocarcinoma
HPB
Hepatology
Gastroenterology
The BET Inhibitor I-Bet762 Inhibits Pancreatic Ductal Adenocarcinoma Cell Proliferation and Enhances the Therapeutic Effect of Gemcitabine
Scientific Reports
Multidisciplinary
Induced Ptf1a Expression in Pancreatic Ductal Adenocarcinoma Cellsactivates Acinar Gene Networks, Reduces Tumorigenic Properties,and Sensitizes Cells to Gemcitabine Treatment
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
